NCT05435118

Brief Summary

Children experience numerous painful experiences from nursing procedures: peripheral venous access placement is the main cause of procedural pain. As much as pharmacological and nonpharmacological tools are known, their application during venipuncture is not systematic by children's hospitals. Among pharmacological tools, the Equimolar Mixture of Nitrogen Protoxide and Oxygen (EMONO) provides adequate protection from procedural pain through inhalation of the gas mixture at least 3 minutes before the procedure. Literature reports that the combination of nonpharmacological distractive tools and pharmacological interventions increases their analgesic effect. The aim of the study is to measure children's cooperation during procedure (primary outcome), pain perception and side effects when EMONO is combined with audiovisuals compared with EMONO alone in peripheral venous access placement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
1.1 years until next milestone

Study Start

First participant enrolled

August 17, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2024

Completed
Last Updated

April 23, 2024

Status Verified

April 1, 2024

Enrollment Period

6 months

First QC Date

May 27, 2022

Last Update Submit

April 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • collaboration

    children cooperation during procedure assessed with Groningen Distress Rating Scale (Humphrey et al., 1992; Herd et al., 2006; Doumit et al., 2016)

    30 minutes

Secondary Outcomes (4)

  • pain perception in 2 years-old children

    30 minutes

  • pain perception in 3 to 5 years-old children

    30 minutes

  • side effect 1

    30 minutes

  • side effect 2

    30 minutes

Study Arms (2)

EMONO (usual care administered to all the children undergoing painful procedures)

NO INTERVENTION

Use of the Equimolar Mixture of Oxide Nitrous and Oxygen (EMONO) with facial mask. In the hospital EMONO is administered to all the children for procedure pain control.

EMONO + audiovisuals tool

EXPERIMENTAL

Use of the Equimolar Mixture of Oxide Nitrous and Oxygen (EMONO) with facial mask and vision of audiovisual toll with smartphone or tablet. The intervention is represented by the audiovisual tool.

Other: EMONO + audiovisuals tool

Interventions

EMONO + use of audiovisuals tool on smartphone or tablet

EMONO + audiovisuals tool

Eligibility Criteria

Age2 Years - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 2 years and 5 years and 364 days
  • Prescription for peripheral venous access placement
  • Parental consent for participation in the study
  • Presence of at least one parent in possession of a smartphone/tablet with the ability to connect to the Internet through Wi-Fi available to users
  • Absence of contraindications to the administration of EMONO reported in health records
  • Absence of facial pathology
  • Presence on duty of at least one experimental nurse trained in the use of EMONO

You may not qualify if:

  • Age less than 2 years and more than 5 years and 364 days
  • No parental consent to participate in the study
  • Parents not in possession of a smartphone/tablet with the ability to connect to the internet through Wi-Fi available to users
  • Presence of contraindications to EMONO administration
  • Presence of facial pathology
  • Oxygen therapy
  • Presence of tracheostomy
  • Absence on duty of at least one experimental nurse trained in the use of EMONO

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stefano Maiandi

Lodi, Lombardy, 26900, Italy

Location

Related Publications (2)

  • Maiandi S, Coluccia S, Ghizzardi G, Nicardi R, Giacchero R, Lusignani M, Gianni ML, Edefonti VC. Effectiveness of Equimolar Mixture of Oxygen and Nitrous Oxide Combined With Audiovisual in Young Children: A Randomised Controlled Trial. Eur J Pain. 2025 Sep;29(8):e70096. doi: 10.1002/ejp.70096.

  • Maiandi S, Ghizzardi G, Edefonti V, Giacchero R, Lusignani M, Gianni ML. Is the equimolar mixture of oxygen and nitrous oxide (EMONO) associated with audiovisuals effective in reducing pain and side effects during peripheral venous access placement in children? Protocol for a single-centre randomised controlled trial from Italy. BMJ Open. 2023 Jul 7;13(7):e067912. doi: 10.1136/bmjopen-2022-067912.

MeSH Terms

Conditions

Acute Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Stefano Maiandi, PhDs

    Azienda Socio Sanitaria Territoriale di Lodi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc PhDs - Health Professionals Directorate

Study Record Dates

First Submitted

May 27, 2022

First Posted

June 28, 2022

Study Start

August 17, 2023

Primary Completion

January 31, 2024

Study Completion

April 22, 2024

Last Updated

April 23, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations